JP2004533826A5 - - Google Patents

Download PDF

Info

Publication number
JP2004533826A5
JP2004533826A5 JP2002582235A JP2002582235A JP2004533826A5 JP 2004533826 A5 JP2004533826 A5 JP 2004533826A5 JP 2002582235 A JP2002582235 A JP 2002582235A JP 2002582235 A JP2002582235 A JP 2002582235A JP 2004533826 A5 JP2004533826 A5 JP 2004533826A5
Authority
JP
Japan
Prior art keywords
primate
polypeptide
drug
transgene
construct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002582235A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004533826A (ja
Filing date
Publication date
Priority claimed from AUPR4467A external-priority patent/AUPR446701A0/en
Application filed filed Critical
Publication of JP2004533826A publication Critical patent/JP2004533826A/ja
Publication of JP2004533826A5 publication Critical patent/JP2004533826A5/ja
Pending legal-status Critical Current

Links

JP2002582235A 2001-04-18 2002-04-18 薬理学的及び毒性学的研究のための非ヒトトランスジェニック動物 Pending JP2004533826A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPR4467A AUPR446701A0 (en) 2001-04-18 2001-04-18 Transgenic mammals for pharmacological and toxicological studies
PCT/AU2002/000485 WO2002083897A1 (en) 2001-04-18 2002-04-18 Transgenic non-human animals for pharmacological and toxicological studies

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008233283A Division JP2009055911A (ja) 2001-04-18 2008-09-11 薬理学的及び毒性学的研究のための非ヒトトランスジェニック動物

Publications (2)

Publication Number Publication Date
JP2004533826A JP2004533826A (ja) 2004-11-11
JP2004533826A5 true JP2004533826A5 (https=) 2008-06-05

Family

ID=3828463

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002582235A Pending JP2004533826A (ja) 2001-04-18 2002-04-18 薬理学的及び毒性学的研究のための非ヒトトランスジェニック動物
JP2008233283A Pending JP2009055911A (ja) 2001-04-18 2008-09-11 薬理学的及び毒性学的研究のための非ヒトトランスジェニック動物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008233283A Pending JP2009055911A (ja) 2001-04-18 2008-09-11 薬理学的及び毒性学的研究のための非ヒトトランスジェニック動物

Country Status (11)

Country Link
US (5) US7544854B2 (https=)
EP (3) EP2336338A3 (https=)
JP (2) JP2004533826A (https=)
KR (1) KR20040015711A (https=)
CN (1) CN1518596A (https=)
AU (2) AUPR446701A0 (https=)
CA (1) CA2444451C (https=)
IL (2) IL158457A0 (https=)
NZ (1) NZ528948A (https=)
WO (1) WO2002083897A1 (https=)
ZA (1) ZA200308062B (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP362898A0 (en) 1998-05-21 1998-06-11 University Of Sydney, The Xenobiotic induction of gene expression
AUPR116100A0 (en) 2000-11-01 2000-11-23 University Of Sydney, The P450 gene regulation
US7449567B2 (en) 2001-04-12 2008-11-11 Xenogen Corporation Isolation and identification of mouse and human transcription control elements associated with cytochrome expression
EP1406917A4 (en) * 2001-06-15 2007-11-14 New Century Pharmaceuticals HUMAN ANALYTICAL MODELS FOR THE EVALUATION OF MEDICINAL PRODUCTS AND FOR TOXICOLOGICAL AND IMMUNOGENIC EXAMINATIONS
WO2004074474A1 (ja) * 2003-02-19 2004-09-02 Shigeki Higashiyama 新規rnaポリメラーゼiiiプロモーター及びその製造方法並びにその使用方法
DE10345837A1 (de) * 2003-10-02 2005-04-21 Bayer Technology Services Gmbh Verfahren zur Bestimmung einer Wirkstoffdosierung
AU2005315438B2 (en) * 2004-12-13 2012-02-23 Iti Scotland Limited Transgenic animals for assessing drug metabolism and toxicity
US7759541B2 (en) 2004-12-13 2010-07-20 Iti Life Sciences Transgenic animals for assessing drug metabolism and toxicity
CN101495499B (zh) * 2005-07-05 2013-09-04 加利福尼亚大学董事会 编码类异戊烯修饰酶的多核苷酸和其使用方法
WO2009063722A1 (ja) * 2007-11-14 2009-05-22 National University Corporation Tottori University ヒトチトクロームp450遺伝子(クラスター)を含む哺乳動物人工染色体ベクター及びそれを保持する非ヒト哺乳動物
KR101722961B1 (ko) 2009-02-11 2017-04-04 알부메딕스 에이/에스 알부민 변이체 및 접합체
BR112012000536A2 (pt) * 2009-07-08 2020-08-11 Kymab Limited métodos para produção de anticorpo ou cadeia leve ou pesada de anticorpo específico para um antígeno desejado, para produção de anticorpo ou cadeia de anticorpo e seu uso, composição farmacêutica e derivado de anticorpo quimérico
CA2776241A1 (en) 2009-10-30 2011-05-05 Novozymes Biopharma Dk A/S Albumin variants
US10233228B2 (en) 2010-04-09 2019-03-19 Albumedix Ltd Albumin derivatives and variants
AU2012312260B2 (en) * 2011-09-21 2017-08-31 Sangamo Therapeutics, Inc. Methods and compositions for regulation of transgene expression
EP2780364A2 (en) 2011-11-18 2014-09-24 Eleven Biotherapeutics, Inc. Proteins with improved half-life and other properties
WO2013135896A1 (en) 2012-03-16 2013-09-19 Novozymes Biopharma Dk A/S Albumin variants
JP5976380B2 (ja) * 2012-04-27 2016-08-23 公益財団法人東京都医学総合研究所 ウロキナーゼ型プラスミノーゲンアクチベータートランスジェニックマウス
MX2015005363A (es) 2012-11-08 2015-11-06 Novozymes Biopharma Dk As Variantes de albumina.
JP6267986B2 (ja) * 2014-02-13 2018-01-24 株式会社特殊免疫研究所 ヒトの特定分子と結合する分子標的物質のinvivo評価法
WO2017029407A1 (en) 2015-08-20 2017-02-23 Albumedix A/S Albumin variants and conjugates
WO2017041020A1 (en) * 2015-09-04 2017-03-09 Oregon State University Renal selective inhibition of cytochrome p450 3a5
US11963520B2 (en) 2016-01-19 2024-04-23 Celgene Corporation Transgenic mouse expressing human cereblon
CN106947816B (zh) * 2016-10-28 2020-08-04 中山大学 一种斜带石斑鱼亲子鉴定微卫星荧光多重pcr的方法
WO2018085967A1 (en) * 2016-11-08 2018-05-17 Guangzhou Institutes Of Biomedicine And Health, Chinese Academy Of Sciences Genetically humanized mammals expressing human serum albumin and uses thereof
CN108977526A (zh) * 2018-06-26 2018-12-11 苏州道尔盾基因科技有限公司 一种他克莫司和环孢素a个体化用药相关snp位点的检测方法及试剂盒
WO2020147829A1 (zh) * 2019-01-17 2020-07-23 北京百奥赛图基因生物技术有限公司 人源化转基因动物
US11622547B2 (en) 2019-06-07 2023-04-11 Regeneran Pharmaceuticals, Inc. Genetically modified mouse that expresses human albumin
CN111899791B (zh) * 2020-06-17 2023-11-24 昆明理工大学 一种基于基因序列相似的病毒源头筛选方法
CN114516910B (zh) * 2020-11-19 2023-11-03 上海茵普森生物医药科技有限公司 一种用于治疗肥胖相关脂肪肝的蛋白质
CN113337540B (zh) * 2021-05-13 2022-06-14 武汉大学 特异性敲除小鼠Treg细胞中Notch2基因的模型构建方法
US20250149121A1 (en) * 2021-08-07 2025-05-08 Venn Biosciences Corporation Detection of peptide structures for diagnosing and treating sepsis and covid
CN114569731B (zh) * 2022-03-01 2023-05-05 山东大学 一种分子信标修饰的纳米载体及在制备抗肿瘤产品中的应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4994384A (en) * 1986-12-31 1991-02-19 W. R. Grace & Co.-Conn. Multiplying bovine embryos
US5057420A (en) * 1987-06-05 1991-10-15 Granada Biosciences, Inc. Bovine nuclear transplantation
GB8901778D0 (en) 1989-01-27 1989-03-15 Univ Court Of The University O Manipulatory technique
US5648597A (en) * 1990-04-20 1997-07-15 University Of South Carolina Alpha-1-acid glycoprotein transgenic mice
AU649066B2 (en) 1990-07-25 1994-05-12 Syngene, Inc. Circular extension for generating multiple nucleic acid complements
ATE352612T1 (de) * 1990-08-29 2007-02-15 Pharming Intellectual Pty Bv Homologe rekombination in säugetier-zellen
WO1992015694A1 (en) 1991-03-08 1992-09-17 The Salk Institute For Biological Studies Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor
JPH06509474A (ja) 1991-07-31 1994-10-27 ローヌ−プーラン・ローラー・インターナシヨナル(ホールデイングス)インコーポレイテツド 蛋白質のトランスジェニック生産
US5422252A (en) 1993-06-04 1995-06-06 Becton, Dickinson And Company Simultaneous amplification of multiple targets
AU714486B2 (en) 1995-11-21 2000-01-06 Yale University Unimolecular segment amplification and detection
AU732508B2 (en) * 1996-01-26 2001-04-26 Governing Council Of The University Of Toronto, The Nucleic acids and proteins related to Alzheimer's disease, and uses therefor
US5994619A (en) * 1996-04-01 1999-11-30 University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus Production of chimeric bovine or porcine animals using cultured inner cell mass cells
EP0941310A1 (en) * 1996-10-11 1999-09-15 THE TEXAS A&M UNIVERSITY SYSTEM Methods for the generation of primordial germ cells and transgenic animal species
US5945577A (en) * 1997-01-10 1999-08-31 University Of Massachusetts As Represented By Its Amherst Campus Cloning using donor nuclei from proliferating somatic cells
US6011197A (en) * 1997-03-06 2000-01-04 Infigen, Inc. Method of cloning bovines using reprogrammed non-embryonic bovine cells
EP1007652A1 (en) 1997-10-02 2000-06-14 Imclone Systems, Inc. Transgenic animals with knocked-in vec receptor genes and uses thereof
US7022893B1 (en) 1998-01-08 2006-04-04 Daiichi Pharmaceutical Co., Ltd. Knockin gene-mutated mouse comprising a mutant presenilin-1 gene
US6258998B1 (en) * 1998-11-24 2001-07-10 Infigen, Inc. Method of cloning porcine animals
JP2001017028A (ja) 1999-05-06 2001-01-23 Mitsubishi Chemicals Corp アポeヒト化哺乳動物
AU6476000A (en) * 1999-08-13 2001-03-13 Kirin Beer Kabushiki Kaisha Mouse having human cytochrome p450 transferred therein
US20020165208A1 (en) * 2000-08-29 2002-11-07 Capdevila Jorge H. Compositions and methods relating to hypertension
EP1330645A4 (en) * 2000-09-21 2005-04-27 Baylor College Medicine SCREENING SYSTEMS AND METHODS FOR IDENTIFYING MODULATORS OF XENOBIOTIC METABOLISM
EP1406917A4 (en) 2001-06-15 2007-11-14 New Century Pharmaceuticals HUMAN ANALYTICAL MODELS FOR THE EVALUATION OF MEDICINAL PRODUCTS AND FOR TOXICOLOGICAL AND IMMUNOGENIC EXAMINATIONS

Similar Documents

Publication Publication Date Title
JP2004533826A5 (https=)
Kitsukawa et al. Neuropilin–semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice
Park et al. MTERF3 is a negative regulator of mammalian mtDNA transcription
Vassalli et al. Minigenes impart odorant receptor-specific axon guidance in the olfactory bulb
Holt et al. Mammalian mitochondrial nucleoids: organizing an independently minded genome
Forlino et al. Use of the Cre/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an α1 (I) G349C substitution: variability in phenotype in BrtlIV mice
Lerch-Gaggl et al. Pescadillo is essential for nucleolar assembly, ribosome biogenesis, and mammalian cell proliferation
Phillips et al. Subunit-destabilizing mutations in Drosophila copper/zinc superoxide dismutase: neuropathology and a model of dimer dysequilibrium.
Gotthardt et al. Conditional expression of mutant M-line titins results in cardiomyopathy with altered sarcomere structure
Neesen et al. Disruption of an inner arm dynein heavy chain gene results in asthenozoospermia and reduced ciliary beat frequency
Cotman et al. Cln3 Δex7/8 knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth
Cartier et al. A frameshift mutation in the γE–crystallin gene of the Elo mouse
US20070266449A1 (en) Generation of animal models
Zhu et al. Stomatocytosis is absent in “stomatin”-deficient murine red blood cells
Kaneko-Goto et al. Goofy coordinates the acuity of olfactory signaling
JP2011500007A5 (https=)
Graw et al. Characterization of a new, dominant V124E mutation in the mouse αA-crystallin–encoding gene
Bogenmann et al. Generation of mice with a conditional allele for the p75NTR neurotrophin receptor gene
Frankel et al. Szt2, a novel gene for seizure threshold in mice
Sakao et al. Mouse proteasomal ATPases Psmc3 and Psmc4: genomic organization and gene targeting
Odeh et al. Mutations in Grxcr1 are the basis for inner ear dysfunction in the pirouette mouse
WO2005003359A1 (ja) トランスジェニック生物を作製する方法およびシステム
Kurokawa et al. Otx2 expression in anterior neuroectoderm and forebrain/midbrain is directed by more than six enhancers
Guay-Woodford et al. Evidence that two phenotypically distinct mouse PKD mutations, bpk and jcpk, are allelic
JP2017532013A (ja) 寿命に関する動物モデル並びに寿命を延ばす及び腫瘍化を阻害する関連方法